Our scientists are making breakthrough discoveries at premier institutions around the world.
*Immunotherapy results may vary from patient to patient.
Cancer Research Institute | National Headquarters
29 Broadway, 4th Floor | New York, NY 10006-3111
(800) 992-2623(212) 832-9376Staff Directory
Nivolumab (Opdivo®) is now available for patients with metastatic and treatment-resistant small cell lung cancer
Gloria Garcia was diagnosed in 2017 with small cell lung cancer. After combination ipilimumab/nivolumab immunotherapy treatment she went into remission.